Growing community of inventors

San Diego, CA, United States of America

Liangjin Zhu

Average Co-Inventor Count = 4.21

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 28

Liangjin ZhuLouie Daniel Garcia (8 patents)Liangjin ZhuWilliam Joseph Lambert (7 patents)Liangjin ZhuGary Patou (6 patents)Liangjin ZhuLois Gibson (2 patents)Liangjin ZhuBenjamin W Li (2 patents)Liangjin ZhuWilliam F Lambert (1 patent)Liangjin ZhuBenjamin Li (0 patent)Liangjin ZhuLiangjin Zhu (8 patents)Louie Daniel GarciaLouie Daniel Garcia (19 patents)William Joseph LambertWilliam Joseph Lambert (7 patents)Gary PatouGary Patou (7 patents)Lois GibsonLois Gibson (2 patents)Benjamin W LiBenjamin W Li (2 patents)William F LambertWilliam F Lambert (4 patents)Benjamin LiBenjamin Li (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pacira Pharmaceuticals, Inc. (8 from 57 patents)


8 patents:

1. 10729651 - Sustained release formulation of a non-steroidal anti-inflammatory drug

2. 10675245 - Sustained release formulation of a non-steroidal anti-inflammatory drug

3. 10617642 - Sustained release formulation of a non-steroidal anti-inflammatory drug

4. 10610486 - Sustained release formulation of a non-steroidal anti-inflammatory drug

5. 10123974 - Sustained release formulation of a non-steroidal anti-inflammatory drug

6. 10028911 - Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

7. 9974744 - Sustained release formulation of a non-steroidal anti-inflammatory drug

8. 9770414 - Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…